Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
The latest announcement is out from Tsumura & Co ( (JP:4540) ).
Tsumura & Co. has concluded its share repurchase program, acquiring 530,400 shares at a total cost of 1,971,140,100 yen. This move, completed on the Tokyo Stock Exchange, marks the end of a strategic initiative resolved by the Board of Directors to enhance shareholder value and optimize capital structure.
The most recent analyst rating on (JP:4540) stock is a Buy with a Yen6000.00 price target. To see the full list of analyst forecasts on Tsumura & Co stock, see the JP:4540 Stock Forecast page.
More about Tsumura & Co
Tsumura & Co. operates in the pharmaceutical industry, focusing on the production and distribution of traditional Japanese Kampo medicines. The company is listed on the Tokyo Stock Exchange and is known for its commitment to integrating traditional herbal medicine with modern healthcare practices.
Average Trading Volume: 527,619
Technical Sentiment Signal: Sell
Current Market Cap: Yen254.9B
Learn more about 4540 stock on TipRanks’ Stock Analysis page.